GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medyssey Co Ltd (XKRX:200580) » Definitions » EBIT

Medyssey Co (XKRX:200580) EBIT : ₩3,825 Mil (TTM As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Medyssey Co EBIT?

Medyssey Co's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2024 was ₩3,825 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2024 was ₩3,825 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Medyssey Co's annualized ROC % for the quarter that ended in Dec. 2024 was 8.24%. Medyssey Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 20.36%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Medyssey Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 19.33%.


Medyssey Co EBIT Historical Data

The historical data trend for Medyssey Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medyssey Co EBIT Chart

Medyssey Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBIT
Get a 7-Day Free Trial Premium Member Only 467.12 5,280.52 4,182.96 2,676.93 3,824.62

Medyssey Co Semi-Annual Data
Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBIT Get a 7-Day Free Trial Premium Member Only 467.12 5,280.52 4,182.96 2,676.93 3,824.62

Competitive Comparison of Medyssey Co's EBIT

For the Medical Devices subindustry, Medyssey Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medyssey Co's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medyssey Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Medyssey Co's EV-to-EBIT falls into.


;
;

Medyssey Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was ₩3,825 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medyssey Co  (XKRX:200580) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Medyssey Co's annualized ROC % for the quarter that ended in Dec. 2024 is calculated as:

ROC % (Q: Dec. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Dec. 2024 ))/ count )
=3191.319 * ( 1 - 33.27% )/( (25946.909 + 25712.219)/ 2 )
=2129.5671687/25829.564
=8.24 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=40268.519 - 5182.624 - ( 9138.986 - max(0, 8143.571 - 28231.877+9138.986))
=25946.909

Invested Capital(Q: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=40352.297 - 3347.394 - ( 11292.684 - max(0, 5788.646 - 29855.059+11292.684))
=25712.219

Note: The Operating Income data used here is one times the annual (Dec. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Medyssey Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Dec. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=3824.619/( ( (7374.029 + max(11224.147, 0)) + (6743.28 + max(12235.411, 0)) )/ 2 )
=3824.619/( ( 18598.176 + 18978.691 )/ 2 )
=3824.619/18788.4335
=20.36 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(10551.887 + 7695.875 + 424.066) - (5182.624 + 0 + 2265.057)
=11224.147

Working Capital(Q: Dec. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(10324.982 + 6978.471 + 482.173) - (3347.394 + 0 + 2202.821)
=12235.411

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (Dec. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Medyssey Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2024 )
=3824.619/19781.340
=19.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medyssey Co EBIT Related Terms

Thank you for viewing the detailed overview of Medyssey Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Medyssey Co Business Description

Traded in Other Exchanges
N/A
Address
129, Hanbang expo-ro, Chungcheongbuk-do, Jecheon-si, KOR, 27116
Medyssey Co Ltd designs, develops, manufactures and markets products for the surgical treatment of spine disorders. It offers products including Thoracolumbar Stabilization, Minimally Invasive, and Interbody Fusion.

Medyssey Co Headlines

No Headlines